Press/Media
- 1 - 25 out of 106 results
Search results
-
Studies from Icahn School of Medicine at Mount Sinai Provide New Data on HIV/AIDS (Clinical Characteristics and Outcomes of Patients with Mpox who Received Tecovirimat in a New York City Health System)
Silvera, R., Bartram, L., Chasan, R., Patel, G., Aberg, J. & Sigel, K.
29/11/23
1 item of Media coverage
Press/Media
-
Moves Power Women Annual Gala & Awards Dinner November 18Th, 2023
18/11/23
89 items of Media coverage
Press/Media
-
Moves Power Women Annual Gala & Awards Dinner November 18Th, 2023
18/11/23
1 item of Media coverage
Press/Media
-
Rukobia Still Effective at Five Years for People With Highly Resistant HIV
8/11/23
1 item of Media coverage
Press/Media
-
Reports from Icahn School of Medicine at Mount Sinai Highlight Recent Findings in HIV/AIDS (Brief Report: Hepatitis B Infection or Reactivation After Switch To 2-drug Antiretroviral Therapy: a Case Series, Literature Review, and Management ...)
Mullen, M. P., Dieterich, D. & Aberg, J.
26/10/23
1 item of Media coverage
Press/Media
-
Mount Sinai Hospital: CastleVax Receives BARDA Project NextGen Award Valued at Up to $338M to Advance Intranasal NDV-Based COVID-19 Booster Vaccine Into Phase 2b Clinical Efficacy Testing
Krammer, F., Palese, P., Garcia-Sastre, A., Aberg, J., Sun, W. & Liu, S. T. H.
19/10/23
1 item of Media coverage
Press/Media
-
Mount Sinai: CastleVax Receives BARDA Project NextGen Award Valued at up to $338 Million to Advance Intranasal NDV-based COVID-19 Booster Vaccine into Phase 2b Clinical Efficacy Testing
Krammer, F., Palese, P., Aberg, J., Sun, W. & Liu, S. T. H.
17/10/23
1 item of Media coverage
Press/Media
-
CastleVax Inc. Receives BARDA Project NextGen Award Valued at up to $338 Million to Advance Intranasal NDV-based COVID-19 Booster Vaccine into Phase 2b Clinical Efficacy Testing
Krammer, F., Palese, P., Garcia-Sastre, A., Aberg, J., Sun, W. & Liu, S. T. H.
17/10/23
2 items of Media coverage
Press/Media
-
-
Daily Statin Medication Reduces Risk of Major Cardiovascular Events by More Than One-Third in People Living with HIV
24/07/23
1 item of Media coverage
Press/Media
-
DAILY STATIN MEDICATION REDUCES RISK OF MAJOR CARDIOVASCULAR EVENTS BY MORE THAN ONE-THIRD IN PEOPLE LIVING WITH HIV
23/07/23
1 item of Media coverage
Press/Media
-
Mass General: Daily Statin Medication Reduces Risk of Major Cardiovascular Events by More Than One-Third in People Living With HIV
23/07/23
1 item of Media coverage
Press/Media
-
Promising Results of Next-Generation Intranasal COVID-19 Booster Vaccine: Implications for Infection Prevention and Transmission
Krammer, F., Palese, P., Garcia-Sastre, A., Aberg, J., Sun, W. & Liu, S. T. H.
20/07/23
1 item of Media coverage
Press/Media
-
Promising Results of Next-Generation Intranasal COVID-19 Booster Vaccine: Implications for Infection Prevention and Transmission
Krammer, F., Palese, P., Garcia-Sastre, A., Aberg, J., Sun, W. & Liu, S. T. H.
20/07/23
1 item of Media coverage
Press/Media
-
Icahn School of Medicine at Mount Sinai: Promising Results of Next-Generation Intranasal COVID-19 Booster Vaccine - Implications for Infection Prevention and Transmission
Krammer, F., Palese, P., Aberg, J., Sun, W. & Liu, S. T. H.
20/07/23
1 item of Media coverage
Press/Media
-
Mount Sinai Researchers Play a Prominent Role in a Wide Probe Into Long COVID
Nadkarni, G., Figueiro, M., Russo, S., Charney, A., Federman, A., Aberg, J. & Liu, S. T. H.
20/07/23
1 item of Media coverage
Press/Media
-
Intranasal Delivery of a Next-Generation NDV-based, COVID-19 Booster Vaccine Shows Promising Mucosal and Systemic Immune Responses
Krammer, F., Palese, P., Garcia-Sastre, A., Charney, D., Aberg, J., Sun, W. & Liu, S. T. H.
13/07/23
78 items of Media coverage
Press/Media
-
Intranasal Delivery of a Next-Generation NDV-based, COVID-19 Booster Vaccine Shows Promising Mucosal and Systemic Immune Responses.
Krammer, F., Palese, P., Garcia-Sastre, A., Charney, D., Aberg, J., Sun, W. & Liu, S. T. H.
13/07/23
1 item of Media coverage
Press/Media